Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma. | Front Oncol | 2022 | 36212459 | PubTator, text mining | PubMed |
| The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36212447 | PubTator, text mining | PubMed |
Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer. | Front Oncol | 2022 | 36212436 | PubTator, text mining | PubMed |
| Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma. | Front Immunol | 2022 | 36211378 | PubTator, text mining | PubMed |
| Clinical observation and risk assessment after splenectomy in hepatolenticular degeneration patients associated with hypersplenism. | Front Surg | 2022 | 36211271 | PubTator, text mining | PubMed |
| Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D-Penicillamine Therapy: A Single Centre Experience. | Ann Indian Acad Neurol | 2022 | 36211139 | PubTator, text mining | PubMed |
| Management of Wilson Disease: The Quest Continues. | Ann Indian Acad Neurol | 2022 | 36211138 | PubTator, text mining | PubMed |
| Screening for Wilson's disease in acute liver failure: A new scoring system in children. | Front Pediatr | 2022 | 36210929 | PubTator, text mining | PubMed |
| Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma. | Biol Direct | 2022 | 36209249 | PubTator, text mining | PubMed |
| Genetic testing of sperm donors at a human sperm bank in China. | Front Endocrinol (Lausanne) | 2022 | 36204111 | PubTator, text mining | PubMed |
| System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. | J Transl Med | 2022 | 36195876 | PubTator, text mining | PubMed |
| Risk model of hepatocellular carcinoma based on cuproptosis-related genes. | Front Genet | 2022 | 36186455 | PubTator, text mining | PubMed |
| Cisplatin for cancer therapy and overcoming chemoresistance. | Heliyon | 2022 | 36158077 | PubTator, text mining | PubMed |
| Hemorrhagic colitis induced by trientine in a 51-year-old patient with Wilson's disease waiting for liver transplantation: A case report. | World J Hepatol | 2022 | 36157863 | PubTator, text mining | PubMed |
| Rotor Syndrome Presenting as Dubin-Johnson Syndrome. | Case Rep Gastroenterol | 2022 | 36157610 | PubTator, text mining | PubMed |
| Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36157462 | PubTator, text mining | PubMed |
| Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma. | Front Genet | 2022 | 36147507 | PubTator, text mining | PubMed |
| Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects. | Pharmaceuticals (Basel) | 2022 | 36145368 | PubTator, text mining | PubMed |
| Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List. | J Pers Med | 2022 | 36143288 | PubTator, text mining | PubMed |
| Successful Derivation of Hepatoblasts, Cholangiocytes and Hepatocytes from Simian Induced Pluripotent Stem Cells. | Int J Mol Sci | 2022 | 36142774 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=50